Literature DB >> 24227932

Digital Merkel cell carcinoma.

Alanna M Rebecca1, Randall O Craft, Anthony A Smith.   

Abstract

Merkel cell carcinoma (MCC) is a rare and biologically aggressive neuroendocrine tumour of the skin. Recent analysis of a surveillance, epidemiology and end results program has shown a statistically significant increase of 8% per year in the age-adjusted rates for MCC of the skin over the past 15 years. MCC commonly presents as a painless, rapidly growing, single red or purple cutaneous nodule. Diagnosis is often delayed until histopathological examination due to the relative rarity of the disease. MCC-specific immunohistochemical markers are available for definitive diagnosis, including anticytokeratin-20-positive stain and thyroid transcription factor-1-negative stains. Because there are no phase III trials to guide management, treatment is often tailored to the individual patient by integrating surgery, radiation and chemotherapy.

Entities:  

Keywords:  Hand tumour; Merkel cell carcinoma; Ray amputation

Year:  2005        PMID: 24227932      PMCID: PMC3822465          DOI: 10.1177/229255030501300407

Source DB:  PubMed          Journal:  Can J Plast Surg        ISSN: 1195-2199


  21 in total

1.  Immunosuppression and Merkel cell cancer.

Authors:  Joseph F Buell; J Trofe; M J Hanaway; T M Beebe; T G Gross; R R Alloway; M R First; E S Woodle
Journal:  Transplant Proc       Date:  2002-08       Impact factor: 1.066

2.  The essential role of radiation therapy in securing locoregional control of Merkel cell carcinoma.

Authors:  W H Morrison; L J Peters; E G Silva; C D Wendt; K K Ang; H Goepfert
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-09       Impact factor: 7.038

Review 3.  Merkel cell tumour: clinical behaviour and treatment.

Authors:  J H Shaw; E Rumball
Journal:  Br J Surg       Date:  1991-02       Impact factor: 6.939

4.  Merkel cell carcinoma can be distinguished from metastatic small cell carcinoma using antibodies to cytokeratin 20 and thyroid transcription factor 1.

Authors:  S N Leech; A J Kolar; P D Barrett; S A Sinclair; N Leonard
Journal:  J Clin Pathol       Date:  2001-09       Impact factor: 3.411

5.  Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma.

Authors:  E Voog; P Biron; J P Martin; J Y Blay
Journal:  Cancer       Date:  1999-06-15       Impact factor: 6.860

6.  Radiotherapy for Merkel cell carcinoma of the skin of the head and neck.

Authors:  M Suntharalingam; M S Rudoltz; W M Mendenhall; J T Parsons; S P Stringer; R R Million
Journal:  Head Neck       Date:  1995 Mar-Apr       Impact factor: 3.147

Review 7.  [The Merkel cell: morphology, developmental origin, function].

Authors:  Z Halata; M Grim; K I Baumann
Journal:  Cas Lek Cesk       Date:  2003-01-20

8.  Trabecular carcinoma of the skin: an ultrastructural study.

Authors:  C K Tang; C Toker
Journal:  Cancer       Date:  1978-11       Impact factor: 6.860

Review 9.  Merkel cell carcinoma. Diagnosis and treatment.

Authors:  M L Haag; L F Glass; N A Fenske
Journal:  Dermatol Surg       Date:  1995-08       Impact factor: 3.398

10.  High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study--TROG 96:07.

Authors:  Michael Poulsen; Danny Rischin; Euan Walpole; Jennifer Harvey; John Mackintosh; Jill Ainslie; Chris Hamilton; Jacqui Keller; Lee Tripcony
Journal:  J Clin Oncol       Date:  2003-12-01       Impact factor: 44.544

View more
  2 in total

1.  Evolving paradigm in treatment of Merkel cell carcinoma of the digit from ray resection to wide local excision and flap coverage.

Authors:  Alex J Doermann; James G Jakowatz; Neil F Jones
Journal:  Hand (N Y)       Date:  2015-04-07

2.  Patient Experiences with Avelumab in Treatment-Naïve Metastatic Merkel Cell Carcinoma: Longitudinal Qualitative Interview Findings from JAVELIN Merkel 200, a Registrational Clinical Trial.

Authors:  Jérémy Lambert; Alexia Marrel; Sandra P D'Angelo; Melissa A Burgess; Bartosz Chmielowski; Nicola Fazio; Thilo Gambichler; Jean-Jacques Grob; Céleste Lebbé; Caroline Robert; Jeffrey Russell; Gülseren Güzel; Murtuza Bharmal
Journal:  Patient       Date:  2020-08       Impact factor: 3.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.